CN1446083A - 具有活性物质可控性释放的涂覆药物剂型 - Google Patents
具有活性物质可控性释放的涂覆药物剂型 Download PDFInfo
- Publication number
- CN1446083A CN1446083A CN99810680A CN99810680A CN1446083A CN 1446083 A CN1446083 A CN 1446083A CN 99810680 A CN99810680 A CN 99810680A CN 99810680 A CN99810680 A CN 99810680A CN 1446083 A CN1446083 A CN 1446083A
- Authority
- CN
- China
- Prior art keywords
- weight
- methyl
- acid
- acrylate
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Abstract
Description
实施例 | 1 | 2 | 3 | 4 | 5 |
核1)撒入混合 | |||||
彩色糖粒 | 700 | 700 | 700 | 700 | 700 |
茶碱 | 901/675/450 | 675 | 420 | 675 | 675 |
醋酸钠 | 450/675/901 | 675 | - | 675 | 675 |
琥珀酸钠/琥珀酸 | 960/700 | ||||
Kollidon25 | 42 | 42 | 43/35 | 42 | 42 |
Aerolsil 200 | 7 | 7 | 7/6 | 7 | 7 |
2)粘合剂溶液 | |||||
Kollidon 30 | 20 | 20 | - | 20 | 20 |
蔗糖 | - | - | 276/97 | - | - |
乙醇 | - | - | 135/28 | - | - |
水 | 380 | 380 | 430/85 | 380 | 380 |
核+涂层 | |||||
包覆核的量 | 500 | 500 | 500 | 500 | 500 |
共聚物1的30%分散液 | 500 | 333/500/667 | 1005 | 83/167/250/333 | 83/167/250/333 |
共聚物2的30%分散液 | - | - | - | 125/167/250/333 | - |
共聚物3的30%分数液 | - | - | - | - | 83/167/250/333 |
柠檬酸三乙酯 | 30 | 27/40/53 | 38 | 10/20/30/40 | 10/20/30/40 |
滑石 | 75 | 50/75100 | 159 | 25/50/75/100 | 25/50/75/100 |
水 | 670 | 447/670/893 | 1179 | 225/447/670/893 | 225/447/670/893 |
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19845358.2 | 1998-10-02 | ||
DE19845358A DE19845358A1 (de) | 1998-10-02 | 1998-10-02 | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1446083A true CN1446083A (zh) | 2003-10-01 |
CN1182840C CN1182840C (zh) | 2005-01-05 |
Family
ID=7883150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998106801A Expired - Fee Related CN1182840C (zh) | 1998-10-02 | 1999-09-28 | 具有活性物质可控性释放的涂覆药物剂型 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6878387B1 (zh) |
EP (1) | EP1117387B1 (zh) |
JP (1) | JP4615124B2 (zh) |
KR (1) | KR100657779B1 (zh) |
CN (1) | CN1182840C (zh) |
AT (1) | ATE286724T1 (zh) |
AU (1) | AU6197499A (zh) |
BR (1) | BR9913104B1 (zh) |
CA (1) | CA2346062C (zh) |
DE (2) | DE19845358A1 (zh) |
ES (1) | ES2234303T3 (zh) |
HK (1) | HK1058152A1 (zh) |
MX (1) | MXPA01003392A (zh) |
PL (1) | PL193899B1 (zh) |
SK (1) | SK285295B6 (zh) |
WO (1) | WO2000019984A2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101484147B (zh) * | 2006-08-18 | 2015-07-08 | 赢创罗姆有限责任公司 | 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物 |
US9237760B2 (en) | 2008-01-10 | 2016-01-19 | Evonik Röhm Gmbh | Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
US10113050B2 (en) | 2009-07-30 | 2018-10-30 | Evonik Roehm Gmbh | Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
US6162466A (en) * | 1999-04-15 | 2000-12-19 | Taro Pharmaceutical Industries Ltd. | Sustained release formulation of carbamazepine |
DE19961334A1 (de) * | 1999-12-17 | 2001-06-21 | Roehm Gmbh | Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
ES2314087T3 (es) * | 2001-03-08 | 2009-03-16 | The Trustees Of The University Of Pennsylvania | Polimeros facialmente anfifilicos como agentes antiinfecciosos. |
DE10127134A1 (de) * | 2001-06-05 | 2002-12-12 | Roehm Gmbh | verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß |
TWI252111B (en) * | 2001-12-14 | 2006-04-01 | Solvay Pharm Gmbh | Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
ATE398445T1 (de) * | 2002-03-28 | 2008-07-15 | Alcon Inc | Co-perlchen von dha und rosmarin und verwendungsverfahren |
DE10250543A1 (de) * | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
MXPA04010956A (es) | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
EP2471527A3 (en) * | 2003-03-17 | 2012-12-12 | The Trustees Of The University Of Pennsylvania | Facially amphiphillc polymers and oligomers and uses thereof |
EP1633358A1 (en) * | 2003-05-20 | 2006-03-15 | Pfizer Products Inc. | Pharmaceutical compositions of varenicline |
DE10332160A1 (de) * | 2003-07-15 | 2005-02-03 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US8313775B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
EP1653925A1 (en) | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
JP5686494B2 (ja) | 2003-08-29 | 2015-03-18 | シオノギ インコーポレイテッド | 抗生物質製剤、その使用法及び作成方法 |
JP2007513869A (ja) | 2003-09-15 | 2007-05-31 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
DE10353186A1 (de) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz |
DE10353196A1 (de) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
EP1711455A4 (en) | 2004-01-23 | 2007-11-07 | Univ Pennsylvania | POLYARYL AND POLYARYLALKYNYL OLIGOMERS AMPHIPHILES AT THE FACIAL LEVEL |
US8715727B2 (en) | 2004-07-02 | 2014-05-06 | Shionogi Inc. | Tablet for pulsed delivery |
AU2005332637B2 (en) * | 2004-07-23 | 2011-04-07 | The Trustees Of The University Of Pennsylvania | Antimicrobial copolymers and uses thereof |
EP2433627A1 (en) * | 2005-02-25 | 2012-03-28 | The Trustees Of The University Of Pennsylvania | Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer |
WO2006102965A1 (en) * | 2005-03-29 | 2006-10-05 | Evonik Röhm Gmbh | Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US9011907B2 (en) * | 2008-01-10 | 2015-04-21 | Evonik Röhm Gmbh | Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
CN105419206B (zh) * | 2009-07-30 | 2017-12-15 | 赢创罗姆有限公司 | 包含共聚物、二羧酸和脂肪单羧酸的粉末状或粒状组合物 |
CA2936740C (en) | 2014-10-31 | 2017-10-10 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
CA3093077A1 (en) * | 2018-03-09 | 2019-09-12 | Evonik Operations Gmbh | Polymer mixture with resistance against the influence of ethanol |
CN110105487B (zh) * | 2018-03-09 | 2021-07-30 | 广州茂丰药业有限公司 | 含季铵基(甲基)丙烯酸酯共聚物的溶液聚合制备方法 |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
SE457505B (sv) | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5292522A (en) * | 1989-06-20 | 1994-03-08 | Rohm Gmbh | Aqueous film coating agent for solid medicaments |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
EP0621032B1 (en) * | 1993-04-23 | 2000-08-09 | Novartis AG | Controlled release drug delivery device |
EP0640341A1 (en) * | 1993-08-27 | 1995-03-01 | Mitsui Toatsu Chemicals, Incorporated | Sustained release pharmaceutical composition and process for producing same |
AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
DE19626045C2 (de) * | 1996-06-28 | 1998-12-03 | Klinge Co Chem Pharm Fab | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
US6159504A (en) * | 1999-01-11 | 2000-12-12 | Kitii Corporation, Ltd. | Core substance-containing calcium microparticles and methods for producing the same |
JP2001139471A (ja) * | 2000-11-20 | 2001-05-22 | Kyoto Pharmaceutical Industries Ltd | 矯味経口用医薬組成物 |
-
1998
- 1998-10-02 DE DE19845358A patent/DE19845358A1/de not_active Withdrawn
-
1999
- 1999-09-28 CN CNB998106801A patent/CN1182840C/zh not_active Expired - Fee Related
- 1999-09-28 KR KR1020017004111A patent/KR100657779B1/ko not_active IP Right Cessation
- 1999-09-28 WO PCT/EP1999/007179 patent/WO2000019984A2/de active IP Right Grant
- 1999-09-28 ES ES99948881T patent/ES2234303T3/es not_active Expired - Lifetime
- 1999-09-28 EP EP99948881A patent/EP1117387B1/de not_active Expired - Lifetime
- 1999-09-28 AU AU61974/99A patent/AU6197499A/en not_active Abandoned
- 1999-09-28 DE DE59911452T patent/DE59911452D1/de not_active Expired - Lifetime
- 1999-09-28 PL PL99347780A patent/PL193899B1/pl unknown
- 1999-09-28 JP JP2000573346A patent/JP4615124B2/ja not_active Expired - Fee Related
- 1999-09-28 SK SK426-2001A patent/SK285295B6/sk not_active IP Right Cessation
- 1999-09-28 CA CA002346062A patent/CA2346062C/en not_active Expired - Fee Related
- 1999-09-28 US US09/787,438 patent/US6878387B1/en not_active Expired - Lifetime
- 1999-09-28 AT AT99948881T patent/ATE286724T1/de active
- 1999-09-28 BR BRPI9913104-8A patent/BR9913104B1/pt not_active IP Right Cessation
- 1999-09-28 MX MXPA01003392A patent/MXPA01003392A/es active IP Right Grant
-
2004
- 2004-02-13 HK HK04101002A patent/HK1058152A1/xx not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101484147B (zh) * | 2006-08-18 | 2015-07-08 | 赢创罗姆有限责任公司 | 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物 |
US9237760B2 (en) | 2008-01-10 | 2016-01-19 | Evonik Röhm Gmbh | Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
US10113050B2 (en) | 2009-07-30 | 2018-10-30 | Evonik Roehm Gmbh | Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid |
Also Published As
Publication number | Publication date |
---|---|
BR9913104B1 (pt) | 2010-11-30 |
BR9913104A (pt) | 2001-05-08 |
ATE286724T1 (de) | 2005-01-15 |
KR100657779B1 (ko) | 2006-12-21 |
HK1058152A1 (en) | 2004-05-07 |
EP1117387B1 (de) | 2005-01-12 |
CN1182840C (zh) | 2005-01-05 |
US6878387B1 (en) | 2005-04-12 |
PL347780A1 (en) | 2002-04-22 |
CA2346062C (en) | 2008-09-16 |
WO2000019984A2 (de) | 2000-04-13 |
SK285295B6 (sk) | 2006-10-05 |
PL193899B1 (pl) | 2007-03-30 |
DE59911452D1 (de) | 2005-02-17 |
KR20010075502A (ko) | 2001-08-09 |
ES2234303T3 (es) | 2005-06-16 |
JP2002526401A (ja) | 2002-08-20 |
CA2346062A1 (en) | 2000-04-13 |
AU6197499A (en) | 2000-04-26 |
EP1117387A2 (de) | 2001-07-25 |
DE19845358A1 (de) | 2000-04-06 |
WO2000019984A3 (de) | 2000-07-20 |
JP4615124B2 (ja) | 2011-01-19 |
MXPA01003392A (es) | 2003-07-21 |
SK4262001A3 (en) | 2002-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1182840C (zh) | 具有活性物质可控性释放的涂覆药物剂型 | |
RU2136283C1 (ru) | Препарат с контролируемым высвобождением лекарства и способ его получения, способ лечения | |
CN1040061C (zh) | 控释药物制剂的制备方法 | |
RU2147231C1 (ru) | Кишечные гранулы дульоксетина | |
US5952005A (en) | Controlled release preparation for administering morphine | |
RU2127587C1 (ru) | Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, (варианты) и способ их получения | |
ES2307044T3 (es) | Forma de medicamento multicapa que contiene una sustancia con actividad moduladora en lo que respeta a la liberacion del principio activo. | |
AU2003246792A1 (en) | Oral suspension of active principle microcapsules | |
JPH03204810A (ja) | 放出制御型製剤およびその製法 | |
JP3804029B2 (ja) | ジルチアゼム処方剤 | |
CN1307613A (zh) | 用于口服或皮肤用药物剂型的涂层剂和粘结剂 | |
JP2005162750A (ja) | 延長された放出抑制性を有するオピオイド製剤 | |
JP2003533470A (ja) | 経口投薬形態における、毒性コアの非毒性領域中へのカプセル化 | |
WO2005046561A2 (de) | Mehrschichtige arzneiform mit einer die abgabe einer modulatorischen substanz beeinflussenden matrix | |
KR20080002789A (ko) | 조절 물질의 전달에 영향을 미치는 매트릭스를 가지는펠렛을 포함하는 다중 미립자 제약 형태 | |
JP4357422B2 (ja) | 強化味覚マスキング能および高溶出速度を有するマイクロカプセル製剤の製造方法 | |
JPH01311024A (ja) | アゼラスチンを含有する調節された作用物質放出性の経口適用医薬調製剤及びその製法 | |
CN101330913A (zh) | 依他普仑的修饰和脉冲释放药物制剂 | |
JPH021405A (ja) | 放出制御型製剤およびその製法 | |
US5492700A (en) | Process and composition for the development of controlled release gemfibrozil dosage form | |
JPS61176536A (ja) | 被覆された投与形態物 | |
US5358723A (en) | Process and composition for the development of controlled release gemfibrozil dosage form | |
CN1043957C (zh) | 口服药物多单元制剂的制备方法 | |
WO1993010775A1 (en) | Process and composition for the development of controlled release gemfibrozil dosage form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ROMA CO., LTD. Free format text: FORMER NAME: ROEHM GMBH Owner name: EVONIK ROEHM GMBH Free format text: FORMER NAME: ROMA CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Darmstadt Patentee after: EVONIK ROHM GmbH Address before: Darmstadt Patentee before: ROHM GmbH Address after: Darmstadt Patentee after: ROHM GmbH Address before: Darmstadt Patentee before: ROHM GmbH & Co.KG |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050105 Termination date: 20180928 |